|
49.
|
|
11 p, 1.5 MB |
Intermittent androgen deprivation therapy : Recommendations to improve the management of patients with prostate cancer following the GRADE approach
/
Bonfill, X. (Xavier) (Institut d'Investigació Biomèdica Sant Pau) ;
Arevalo-Rodriguez, Ingrid (Hospital Ramon y Cajal (IRYCIS)) ;
Martínez García, Laura (Institut d'Investigació Biomèdica Sant Pau) ;
Quintana Ruiz, Maria Jesús (Institut d'Investigació Biomèdica Sant Pau) ;
Buitrago-Garcia, Diana (Universidad Tecnológica Equinoccial) ;
Lobos Urbina, D. (Pontificia Universidad Católica de Chile) ;
Cordero, José Antonio (Universitat Ramon Llull) ;
Universitat Autònoma de Barcelona
The purpose of this study was to provide evidence-based recommendations of intermittent androgen deprivation therapy (IADT) compared with continuous androgen deprivation therapy (CADT) for men with prostate cancer (PCA). [...]
2018 -  10.2147/CMAR.S164856
Cancer Management and Research, Vol. 10 (2018) , p. 2357-2367
|
|
|
50.
|
|
12 p, 813.5 KB |
Carotid blowout syndrome : Modern trends in management
/
Suárez, C. (Universidad de Oviedo) ;
Fernández-Alvarez, Verónica (Hospital Universitario de Cabueñes (Gijón)) ;
Hamoir, Marc (St Luc University Hospital) ;
Mendenhall, W.M. (University of Florida) ;
Strojan, Primož (Institute of Oncology of Ljubljana) ;
Quer, Miquel (Institut d'Investigació Biomèdica Sant Pau) ;
Silver, C.E. (University of Arizona) ;
Rodrigo, Juan Pablo (Hospital Universitario Central de Asturias) ;
Rinaldo, Alessandra (University of Udine School of Medicine) ;
Ferlito, Alfio (International Head and Neck Scientific Group) ;
Universitat Autònoma de Barcelona
Carotid blowout syndrome (CBS) refers to rupture of the carotid artery and is an uncommon complication of head and neck cancer that can be rapidly fatal without prompt diagnosis and intervention. CBS develops when a damaged arterial wall cannot sustain its integrity against the patient's blood pressure, mainly in patients who have undergone surgical procedures and radiotherapy due to cancer of the head and neck, or have been reirradiated for a recurrent or second primary tumor in the neck. [...]
2018 - 10.2147/CMAR.S180164
Cancer Management and Research, Vol. 10 (2018) , p. 5617-5628
|
|
|
51.
|
|
26 p, 596.2 KB |
Un nuevo caso de refundición : de "La prueba de los ingenios" a "Hacer remedio el dolor"
/
Castrillo Alaguero, Javier (Universidad de Burgos)
La producción dramática de Agustín Moreto representa uno de los casos más llamativos del Siglo de Oro español, puesto que gran parte de sus obras se basa en la reescritura de comedias anteriores. [...]
The dramatic production of Agustín Moreto represents one of the most striking cases of the Spanish Golden Age, since a large part of his works are based on the recasting of previous plays. This article analyzes a new case of recasting, in this case, a collaborative comedy, Hacer remedio el dolor, which rewrites an earlier work by Lope de Vega, La prueba de los ingenios. [...]
2023 - 10.5565/rev/studiaaurea.530
Studia aurea : revista de literatura española y teoría literaria del Renacimiento y Siglo de Oro, Vol. 17 (2023) , p. 227-252 (Artículos)
|
|
|
52.
|
|
10 p, 598.4 KB |
Values and preferences of men for undergoing prostate-specific antigen screening for prostate cancer : a systematic review
/
Vernooij, Robin W.M. (Netherlands Comprehensive Cancer Organisation) ;
Lytvyn, Lyubov (McMaster University (Canadà)) ;
Pardo-Hernandez, Hector (Institut d'Investigació Biomèdica Sant Pau) ;
Albarqouni, Loai (Bond University) ;
Canelo Aybar, Carlos Gilberto (Universidad Peruana de Ciencias Aplicadas) ;
Campbell, Karen (McMaster University (Canadà)) ;
Agoritsas, Thomas (Geneva University Hospitals) ;
Universitat Autònoma de Barcelona
To investigate men's values and preferences regarding prostate-specific antigen (PSA)-based screening for prostate cancer. Systematic review. We searched MEDLINE, EMBASE, PsycINFO and grey literature up to 2 September 2017. [...]
2018 - 10.1136/bmjopen-2018-025470
BMJ open, Vol. 8 Núm. 9 (2018) , p. e025470
|
|
|
53.
|
|
12 p, 2.4 MB |
The use of HPV16-E5, EGFR, and PEGFR as prognostic biomarkers for oropharyngeal cancer patients
/
Taberna, Miren (Hospital Universitari de Bellvitge) ;
Torres, Montserrat (Hospital Universitari de Bellvitge) ;
Alejo, María (Hospital General de l'Hospitalet) ;
Mena, Marisa (Centro de Investigación Biomédica en Red de Cáncer) ;
Tous, Sara (Centro de Investigación Biomédica en Red de Cáncer) ;
Marquez, Sandra (Hospital Universitari de Bellvitge) ;
Pavón, Miquel A. (Hospital Universitari de Bellvitge) ;
León, Xavier (Institut d'Investigació Biomèdica Sant Pau) ;
Garcia Lorenzo, J (Hospital de la Santa Creu i Sant Pau (Barcelona, Catalunya)) ;
Guix, Marta (Hospital del Mar (Barcelona, Catalunya)) ;
Hijano, Rafael (Hospital del Mar (Barcelona, Catalunya)) ;
Bonfill Abella, Teresa (Parc Taulí Hospital Universitari. Institut d'Investigació i Innovació Parc Taulí (I3PT)) ;
Aguilà, Antón (Parc Taulí Hospital Universitari. Institut d'Investigació i Innovació Parc Taulí (I3PT)) ;
Lozano, Alicia (Hospital Universitari de Bellvitge) ;
Mesía, Ricard (Hospital Universitari de Bellvitge) ;
Alemany, Laia (Hospital Universitari de Bellvitge) ;
Bravo, Ignacio G. (Laboratory MIVEGEC (CNRS IRD Uni Montp)) ;
Universitat Autònoma de Barcelona
Anti-epidermal-growth-factor-receptor (EGFR) therapies in combination with radiotherapy are being studied on deescalation clinical trials for HPV-related oropharyngeal cancer (OPC) patients. The HPV16-E5 oncoprotein increases recycling of activated EGFR to the cell surface, enhancing factor signal transduction. [...]
2018 - 10.3389/fonc.2018.00589
Frontiers in Oncology, Vol. 8 Núm. DEC (2018) , p. 589
|
|
|
54.
|
|
11 p, 639.3 KB |
Seroprevalence and immunological memory against SARS-CoV-2 in lung cancer patients : the SOLID study
/
Provencio, Mariano (Hospital Universitario Puerta de Hierro Majadahonda (Madrid)) ;
Rodríguez-Abreu, Delvys (Hospital Universitario Insular de Gran Canaria) ;
Ortega Granados, Ana Laura (Hospital Universitario de Jaén) ;
Serrano, Gloria (Hospital Universiario Infanta Leonor (Madrid)) ;
Aguado, Carlos (Hospital Clínico San Carlos (Madrid)) ;
Franco, Fernando (Hospital Universitario Puerta de Hierro Majadahonda (Madrid)) ;
Gutierrez, Vanesa (Hospital Universitario Regional de Málaga) ;
López-Vivanco, Guillermo (Hospital Universitario Cruces (Barakaldo, País Basc)) ;
Guirado Risueño, María (Hospital General Universitario de Elche) ;
Benítez, Gretel (Hospital Universitario Insular de Gran Canaria) ;
Estival, Anna (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ;
Calvo, Virginia (Hospital Universitario Puerta de Hierro Majadahonda) ;
Jiménez, Beatriz (Hospital Universitario HM Sanchinarro (Madrid)) ;
Arasanz, Hugo (Complejo Hospitalario Navarra-Navarrabiomeed) ;
Coves, Juan (Hospital Universitari Son LLàtzer (Palma de Mallorca, Balears)) ;
Majem, Margarita (Institut d'Investigació Biomèdica Sant Pau) ;
Massutí, Bartomeu (Hospital General Universitario de Alicante (Alacant, País Valencià)) ;
Vázquez, Sergio (Hospital Universitario Lucus Augusti (Lugo)) ;
Juan, Óscar (Hospital Universitario y Politécnico La Fe) ;
Collazo-Lorduy, Ana (Hospital Universitario Puerta de Hierro Majadahonda (Madrid)) ;
Gozálvez, Clara L. (Hospital Universitari Sant Joan de Reus (Tarragona)) ;
Barco, Edel D. (Hospital Clínico Universitario (Salamanca)) ;
Rosero, Adriana (Hospital Universitario Infanta Cristina) ;
Bosch-Barrera, J. (Institut Català d'Oncologia) ;
Moreno, María A. (Hospital Universitario de Puerto Real (Cadis)) ;
Mielgo-Rubio, X. (Hospital Universitario Fundación Alcorcón) ;
Villa, J.C. (Hospital General Universitario Ciudad Real) ;
López-Martin, A. (Hospital Universitario Severo Ochoa) ;
Córdoba Ortega, Juan Felipe (Hospital Universitario Arnau de Vilanova) ;
de Asís Aparisi, F. (Hospital General Universitario de Valencia) ;
Zafra, M. (Hospital General Universitario Morales Meseguer (Múrcia)) ;
Mosquera, J. (Complejo Hospitalario Universitario de A Coruña) ;
Altozano, J.P. (Hospital Virgen de los Lirios) ;
Nadal, E. (Institut Català d'Oncologia. Hospitalet de Llobregat) ;
Catot, S. (Altaia. Xarxa Assistencial Universitaria Manresa) ;
Balsalobre, J. (Hospital General Universitario Santa Lucia Cartagena) ;
de Portugal, T. (Complejo Hospitalario de Zamora) ;
Martín, P. (Hospital Clínic Universitari (València)) ;
de Juan, S.C. (Laboratorio Central) ;
Cobo, M. (Hospital Universitario Regional de Málaga) ;
Universitat Autònoma de Barcelona
At present, we did not find any articles that studied seroprevalence and its persistence several months later in lung cancer patients in the setting of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. [...]
2022 - 10.21037/tlcr-21-504
Translational Lung Cancer Research, Vol. 11 Núm. 1 (january 2022) , p. 53-63
|
|
|
55.
|
|
12 p, 2.4 MB |
Interim Results from the IMPACT Study : Evidence for Prostate-specific Antigen Screening in BRCA2 Mutation Carriers
/
Page, Elizabeth C. (Institute of Cancer Research) ;
Bancroft, Elizabeth K. (Royal Marsden NHS Foundation Trust) ;
Brook, Mark N. (Institute of Cancer Research) ;
Assel, Melissa (Memorial Sloan Kettering Cancer Center) ;
Hassan Al Battat, Mona (Lund University) ;
Thomas, Sarah (Royal Marsden NHS Foundation Trust) ;
Taylor, Natalie (Royal Marsden NHS Foundation Trust) ;
Chamberlain, Anthony (Institute of Cancer Research) ;
Pope, Jennifer (Institute of Cancer Research) ;
Raghallaigh, Holly Ni (Institute of Cancer Research) ;
Evans, D.Gareth (Central Manchester University Hospitals NHS Foundation Trust) ;
Rothwell, Jeanette (Central Manchester University Hospitals NHS Foundation Trust) ;
Maehle, Lovise (Oslo University Hospital (Oslo, Noruega)) ;
Grindedal, Eli Marie (Oslo University Hospital (Oslo, Noruega)) ;
James, Paul (The Royal Melbourne Hospital) ;
Mascarenhas, Lyon (Peter MacCallum Cancer Centre) ;
McKinley, Joanne (Peter MacCallum Cancer Centre) ;
Side, Lucy (Princess Anne Hospital) ;
Thomas, Tessy (Princess Anne Hospital) ;
van Asperen, Christi (Leiden University Medical Center) ;
Vasen, Hans (The Foundation for the Detection of Hereditary Cancer) ;
Kiemeney, Lambertus A. (Radboud University Medical Center) ;
Ringelberg, Janneke (The Foundation for the Detection of Hereditary Cancer) ;
Jensen, Thomas Dyrso. (Vejle Hospital) ;
Osther, Palle J.S. (Vejle Hospital) ;
Helfand, Brian T. (NorthShore University HealthSystem) ;
Genova, Elena (NorthShore University HealthSystem) ;
Oldenburg, Rogier A. (Erasmus University Medical Center) ;
Cybulski, Cezary (Pomeranian Medical University in Szczecin) ;
Wokolorczyk, Dominika (Pomeranian Medical University in Szczecin) ;
Ong, Kai-Ren (Birmingham Women's Hospital) ;
Huber, Camilla (Birmingham Women's Hospital) ;
Lam, Jimmy (Bedford Park) ;
Taylor, Louise (Daw Park) ;
Salinas, Monica (Hospital Universitari de Bellvitge) ;
Feliubadaló, Lidia (Hospital Universitari de Bellvitge) ;
Oosterwijk, Jan C. (University of Groningen) ;
van Zelst-Stams, Wendy (Radboud University Medical Center) ;
Cook, Jackie (Sheffield Children's Hospital (Sheffield, Regne Unit)) ;
Rosario, Derek J. (Royal Hallamshire Hospital) ;
Domchek, Susan (Basser Research Center. University of Pennsylvania) ;
Powers, Jacquelyn (University of Pennsylvania) ;
Buys, Saundra (University of Utah) ;
O'Toole, Karen (University of Utah) ;
Ausems, Margreet G. E. M (University Medical Centre) ;
Schmutzler, Rita K. (University Hospital Cologne) ;
Rhiem, Kerstin (University Hospital Cologne) ;
Izatt, Louise (Guy's and St Thomas' NHS Foundation Trust) ;
Tripathi, Vishakha (Guy's and St Thomas' NHS Foundation Trust) ;
Teixeira, Manuel R. (Porto University) ;
Cardoso, Marta (Portuguese Oncology Institute (IPO Porto)) ;
Foulkes, William D. (McGill University, Departments of Human Genetics and Oncology) ;
Aprikian, Armen (Research Institute of McGill University Health Centre) ;
van Randeraad, Heleen (The Foundation for the Detection of Hereditary Cancer) ;
Davidson, Rosemarie (Queen Elizabeth University Hospital) ;
Longmuir, Mark (Queen Elizabeth University Hospital) ;
Ruijs, Marielle W.G. (The Netherlands Cancer Institute (Amsterdam, Països Baixos)) ;
Helderman van den Enden, Apollonia T.J.M. (Maastricht University Medical Center) ;
Adank, Muriel (Amsterdam UMC) ;
Williams, Rachel (Prince of Wales Hospital (Australia)) ;
Andrews, Lesley (Prince of Wales Hospital (Australia)) ;
Murphy, Declan G. (Peter MacCallum Cancer Centre) ;
Halliday, Dorothy (Oxford Centre for Genomic Medicine) ;
Walker, Lisa (Oxford Centre for Genomic Medicine) ;
Liljegren, Annelie (Karolinska University Hospital and Karolinska Institutet (Suecia)) ;
Carlsson, Stefan (Karolinska University Hospital and Karolinska Institutet (Suecia)) ;
Azzabi, Ashraf (Newcastle upon Tyne Hospitals) ;
Jobson, Irene (Newcastle upon Tyne Hospitals) ;
Morton, Catherine (The Royal Melbourne Hospital) ;
Shackleton, Kylie (The Royal Melbourne Hospital) ;
Snape, Katie (St George's Hospital) ;
Hanson, Helen (St George's Hospital) ;
Harris, Marion (Monash Health) ;
Tischkowitz, Marc (University of Cambridge) ;
Taylor, Amy (Cambridge University Hospitals NHS Trust) ;
Kirk, Judy (Sydney Medical School) ;
Susman, Rachel (Royal Brisbane & Women's Hospital) ;
Chen-Shtoyerman, Rakefet (Kaplan Medical Center) ;
Spigelman, Allan (The Kinghorn Cancer Centre. St Vincent's Hospital) ;
Pachter, Nicholas (University of Western Australia) ;
Ahmed, Munaza (NE Thames Regional Genetics Service) ;
Ramon y Cajal, Teresa (Institut d'Investigació Biomèdica Sant Pau) ;
Zgajnar, Janez (Institute of Oncology) ;
Brewer, Carole (Royal Devon and Exeter Hospital) ;
Gadea, Neus (Hospital Universitari Vall d'Hebron) ;
Brady, Angela F. (London North West University Healthcare NHS Trust) ;
van Os, Theo (Academic Medical Center) ;
Gallagher, David (St James's Hospital) ;
Johannsson, Oskar (Landspitali University Hospital (Reykjavík, Islàndia)) ;
Donaldson, Alan (St Michael's Hospital) ;
Barwell, Julian (University Hospitals Leicester) ;
Nicolai, Nicola (Istituto Nazionale dei Tumori (Milà, Itàlia)) ;
Friedman, Eitan (Chaim Shema Medical Center) ;
Obeid, Elias (Fox Chase Cancer Center) ;
Greenhalgh, Lynn (Liverpool Women's Hospital) ;
Murthy, Vedana (Tata Memorial Centre) ;
Copakova, Lucia (National Cancer Institute) ;
Saya, Sibel (Institute of Cancer Research) ;
McGrath, John (University of Exeter Medical School) ;
Cooke, Peter (New Cross Hospital) ;
Rønlund, Karina (Vejle Hospital) ;
Richardson, Kate (Peter MacCallum Cancer Centre) ;
Henderson, Alex (West Cumberland Infirmary) ;
Teo, Soo H. (Subang Jaya Medical Centre) ;
Arun, Banu (The University of Texas) ;
Kast, Karin (Technische Universität Dresden) ;
Dias, Alexander (Instituto Nacional de Cancer Jose de Alencar Gomes da Silva (INCA)) ;
Aaronson, Neil K (The Netherlands Cancer Institute (Amsterdam, Països Baixos)) ;
Ardern-Jones, Audrey (Royal Marsden NHS Foundation Trust) ;
Bangma, Chris H. (Erasmus University Medical Center) ;
Castro, Elena (Centro Nacional de Investigaciones Oncológicas) ;
Dearnaley, David (The Institute of Cancer Research. Royal Marsden NHS Foundation Trust (Londres, Regne Unit)) ;
Eccles, Diana M. (The University of Southampton Medical School) ;
Tricker, Karen (Central Manchester University Hospitals NHS Foundation Trust) ;
Eyfjord, Jorunn (University of Iceland) ;
Falconer, Alison (Imperial College Healthcare NHS Trust) ;
Foster, Christopher (HCA Pathology Laboratories) ;
Gronberg, Henrik (University Hospital) ;
Hamdy, Freddie C. (University of Oxford) ;
Stefansdottir, Vigdis (Landspitali University Hospital (Reykjavík, Islàndia)) ;
Khoo, Vincent (The University of Melbourne) ;
Lindeman, Geoffrey J. (The Walter and Eliza Hall Institute of Medical Research) ;
Lubinski, Jan (Pomeranian Medical University in Szczecin) ;
Axcrona, Karol (Akershus University Hospital) ;
Mikropoulos, Christos (Medway Hospital) ;
Mitra, Anita (University College London Hospitals NHS Foundation Trust) ;
Moynihan, Clare (Institute of Cancer Research) ;
Rennert, Gadi (Carmel Medical Center) ;
Suri, Mohnish (Nottingham City Hospital) ;
Wilson, Penny (Innovate UK. Polaris House) ;
Dudderidge, Tim (University Hospital Southampton) ;
Offman, Judith (King's College London) ;
Kote-Jarai, Zsofia (Institute of Cancer Research) ;
Vickers, Andrew (Memorial Sloan Kettering Cancer Center) ;
Lilja, Hans (Memorial Sloan-Kettering Cancer Center (Nova York, Estats Units d'Amèrica)) ;
Eeles, Rosalind A. (Royal Marsden NHS Foundation Trust) ;
Universitat Autònoma de Barcelona
Mutations in BRCA2 cause a higher risk of early-onset aggressive prostate cancer (PrCa). The IMPACT study is evaluating targeted PrCa screening using prostate-specific-antigen (PSA) in men with germline BRCA1/2 mutations. [...]
2019 - 10.1016/j.eururo.2019.08.019
European Urology, Vol. 76 Núm. 6 (december 2019) , p. 831-842
|
|
|
56.
|
|
9 p, 372.6 KB |
Systematic review on women's values and preferences concerning breast cancer screening and diagnostic services
/
Mathioudakis, Alexander G. (University of Manchester) ;
Salakari, Minna (University of Turku) ;
Pylkkanen, Liisa (Finnish Medicines Agency Fimea) ;
Saz-Parkinson, Zuleika (European Commission) ;
Bramesfeld, Anke (Hanover Medical School) ;
Deandrea, Silvia (Health Protection Agency of Pavia) ;
Lerda, Donata (European Commission) ;
Neamtiu, L. (European Commission) ;
Pardo-Hernandez, Héctor (Centro de Investigación Biomédica en Red de Epidemiología y Salud Pública) ;
Solà, Ivan (Institut d'Investigació Biomèdica Sant Pau) ;
Alonso-Coello, Pablo (Institut d'Investigació Biomèdica Sant Pau) ;
Universitat Autònoma de Barcelona
There is still lack of consensus on the benefit-harm balance of breast cancer screening. In this scenario, women's values and preferences are crucial for developing health-related recommendations. In the context of the European Commission Initiative on Breast Cancer, we conducted a systematic review to inform the European Breast Guidelines. [...]
2019 - 10.1002/pon.5041
Psycho-Oncology, Vol. 28 Núm. 5 (may 2019) , p. 939-947
|
|
|
57.
|
|
10 p, 1.6 MB |
Assessment of the level III of Inoue by preoperative endoscopic ultrasound and elastography : a novel approach to predict a periarterial divestment technique in borderline resectable (BR) or locally advanced (LA) pancreatic adenocarcinoma-How I do it
/
Alberti Delgado, Piero (Universitat Autònoma de Barcelona. Departament de Cirurgia) ;
Pando, Elizabeth (Universitat Autònoma de Barcelona. Departament de Cirurgia) ;
Abu-Suboh Abadia, Monder (Hospital Universitari Vall d'Hebron) ;
Masachs, Miquel (Hospital Universitari Vall d'Hebron) ;
Merino, Xavier (Hospital Universitari Vall d'Hebron) ;
Salcedo, Maite (Hospital Universitari Vall d'Hebron) ;
Macarulla Mercadé, Teresa (Vall d'Hebron Institut d'Oncologia) ;
Balsells, Joaquim (Hospital Universitari Vall d'Hebron) ;
Charco, Ramon (Hospital Universitari Vall d'Hebron)
Background: Periarterial divestment is a surgical technique to approach borderline resectable (BR) or locally advanced (LA) pancreatic ductal adenocarcinoma (PDAC) with arterial involvement. There are no reports in the literature regarding the role of endoscopic ultrasound and elastography (EUS-EG) in exploring the integrity of Inoue's level III and its correlation with the periarterial divestment technique feasibility. [...]
2023 - 10.1007/s00423-023-03105-x
Langenbeck's archives of surgery, Vol. 408 (2023) , art. 367
|
|
|
58.
|
|
28 p, 397.3 KB |
EAU-EANM-ESTRO-ESUR-SIOG Prostate Cancer Guideline Panel Consensus Statements for Deferred Treatment with Curative Intent for Localised Prostate Cancer from an International Collaborative Study (DETECTIVE Study)
/
Lam, Thomas B.L. (Aberdeen Royal Infirmary) ;
MacLennan, Steven (University of Aberdeen) ;
Willemse, Peter-Paul M. (University Medical Center Utrecht) ;
Mason, Malcolm D. (Velindre Cancer Centre) ;
Plass, Karin (EAU Guidelines Office) ;
Shepherd, Robert (EAU Guidelines Office) ;
Baanders, Ruud ;
Bangma, Chris H. (Erasmus University Medical Centre) ;
Bjartell, Anders (Lund University) ;
Bossi, Alberto (Gustave Roussy Institute) ;
Briers, Erik ;
Briganti, Alberto (IRCCS Ospedale San Raffaele (Milà, Itàlia)) ;
Buddingh, Karel T. (HagaZiekenhuis) ;
Catto, James W.F. (Royal Hallamshire Hospital) ;
Colecchia, Maurizio (Fondazione IRCCS Istituto Nazionale dei Tumori di Milano) ;
Cox, Brett W. (Zucker School of Medicine) ;
Cumberbatch, Marcus G. (University of Sheffield) ;
Davies, Jeff ;
Davis, Niall F. (Royal College of Surgeons in Ireland) ;
De Santis, Maria (Charité University Hospital) ;
Dell'Oglio, Paolo (ORSI Academy) ;
Deschamps, André (Europa Uomo) ;
Donaldson, James F. (Aberdeen Royal Infirmary) ;
Egawa, Shin (Jikei University School of Medicine) ;
Fankhauser, Christian D. (University of Zurich) ;
Fanti, Stefano (University of Bologna) ;
Fossati, Nicola (Scientific Institute and University Vita-Salute San Raffaele Hospital) ;
Gandaglia, Giorgio (IRCCS Ospedale San Raffaele) ;
Gillessen, Silke (University of Bern) ;
Grivas, Nikolaos (The Netherlands Cancer Institute (Amsterdam, Països Baixos)) ;
Gross, Tobias (University of Bern) ;
Grummet, Jeremy P. (Monash University) ;
Henry, Ann M. (St. James's University Hospital) ;
Ingels, Alexandre (Henri Mondor Hospital) ;
Irani, Jacques (University Hospital of Bicêtre-Paris Sud-Saclay University) ;
Lardas, Michael (Department of Reconstructive Urology and Surgical Andrology) ;
Liew, Matthew (Wigan and Leigh NHS Foundation Trust) ;
Lin, Daniel W. (University of Washington) ;
Moris, Lisa (KU Leuven) ;
Omar, Muhammad Imran (University of Aberdeen) ;
Pang, Karl H. (University of Sheffield) ;
Paterson, Catherine C. (Robert Gordon University) ;
Renard-Penna, Raphaële (Sorbonne Université) ;
Ribal, María J. (Hospital Clínic i Provincial de Barcelona) ;
Roobol, M.J. (Erasmus University Medical Centre) ;
Rouprêt, Morgan (Sorbonne Université) ;
Rouvière, Olivier (Université de Lyon) ;
Sancho-Pardo, Gemma (Institut d'Investigació Biomèdica Sant Pau) ;
Richenberg, Jonathan (Royal Sussex County Hospital Brighton and Brighton and Sussex Medical School) ;
Schoots, Ivo G. (Erasmus University Medical Center) ;
Sedelaar, J.P.Michiel (Radboud University Medical Centre) ;
Stricker, Phillip (Garvan Institute of Research) ;
Tilki, Derya (University Hospital Hamburg-Eppendorf) ;
Vahr Lauridsen, Susanne (Copenhagen University Hospital) ;
van den Bergh, Roderick C.N. (St. Antonius Hospital) ;
Van den Broeck, Thomas (University Hospitals Leuven (Bèlgica)) ;
van der Kwast, Theodorus H. (Erasmus University Medical Center) ;
van der Poel, Henk G. (The Netherlands Cancer Institute (Amsterdam, Països Baixos)) ;
van Leenders, Geert J.L.H. (Erasmus University Medical Center) ;
Varma, Murali (University Hospital of Wales) ;
Violette, Philippe D. (McMaster University (Canadà)) ;
Wallis, Christopher J.D. (Vanderbilt University Medical Center) ;
Wiegel, Thomas (University Hospital of Ulm (Alemanya)) ;
Wilkinson, Karen (University College London Hospitals) ;
Zattoni, Fabio (Academic Medical Centre Hospital) ;
N'Dow, James M.O. (Aberdeen Royal Infirmary) ;
Van Poppel, Hendrik (University Hospitals Leuven (Bèlgica)) ;
Cornford, Philip (Royal Liverpool and Broadgreen Hospitals NHS Trust) ;
Mottet, Nicolas (University Hospital Jean Monnet) ;
Universitat Autònoma de Barcelona
There is uncertainty in deferred active treatment (DAT) programmes, regarding patient selection, follow-up and monitoring, reclassification, and which outcome measures should be prioritised. To develop consensus statements for all domains of DAT. [...]
2019 - 10.1016/j.eururo.2019.09.020
European Urology, Vol. 76 Núm. 6 (december 2019) , p. 790-813
|
|
visitant ::
identificació
alerta personal via correu electrònic o subscribiu-vos al 
canal RSS.
